Section Arrow
CYTK.NASDAQ
- Cytokinetics
Quotes are at least 15-min delayed:2025/06/02 00:16 EDT
Last
 31.02
-0.3 (-0.96%)
Day High 
31.42 
Prev. Close
31.32 
1-M High
43.51 
Volume 
1.25M 
Bid
30
Ask
31.55
Day Low
30.26 
Open
31.41 
1-M Low
29.31 
Market Cap 
3.74B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 30.87 
20-SMA 32.48 
50-SMA 37.19 
52-W High 61.38 
52-W Low 29.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.29/-5.57
Enterprise Value
4.50B
Balance Sheet
Book Value Per Share
-2.23
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
18.47M
Operating Revenue Per Share
0.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed:2025/06/02 00:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.